Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Net Income: 2023-2024

Historic Net Income for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to -$88.0 million.

  • CG Oncology's Net Income fell 114.22% to -$43.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$151.4 million, marking a year-over-year decrease of 107.99%. This contributed to the annual value of -$88.0 million for FY2024, which is 81.36% down from last year.
  • Latest data reveals that CG Oncology reported Net Income of -$88.0 million as of FY2024, which was down 81.36% from -$48.5 million recorded in FY2023.
  • Over the past 5 years, CG Oncology's Net Income peaked at -$48.5 million during FY2023, and registered a low of -$88.0 million during FY2024.
  • Its 2-year average for Net Income is -$68.3 million, with a median of -$68.3 million in 2023.
  • Data for CG Oncology's Net Income shows a maximum YoY plummeted of 81.36% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows CG Oncology's Net Income stood at -$48.5 million in 2023, then tumbled by 81.36% to -$88.0 million in 2024.